Jonas Schoendube
Direttore/Membro del Consiglio presso Cytena Bioprocess Solutions
Provenienza dei contatti di primo grado di Jonas Schoendube
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
cytena GmbH
 cytena GmbH BiotechnologyHealth Technology cytena GmbH develops a device for separating of single cells. It has developed a device called cy-Clone to separate single cells and these single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research, the cy-Clone is supported by an automated imaging process to encapsulate cells in droplets, which are delivered to any type of substrate. The company was founded by Peter Koltay, Benjamin Steimle, Jonas Schoendube and Andre Gross in August 2014 and is headquartered in Freiburg, Germany.
3
| Subsidiary | Biotechnology | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jonas Schoendube tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|
Statistiche
Distribuzione geografica
Settori
Posizioni
| Founder | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Director of Finance/CFO | 1 |
| Public Communications Contact | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Andre Gross | 1 |
| Peter Koltay | 1 |
| Benjamin Steimle | 1 |
- Borsa valori
- Insiders
- Jonas Schoendube
- Connessioni Società
